1-4 of 4
James A. Russell, MBBChir
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fludarabine-Busulfan Conditioning and In Vivo T-Cell Depletion with Reduced Dose of ATG Followed by Allografting Induces Durable Responses in Patients with Advanced Multiple Myeloma with No Grade III-IV aGvHD.

Nizar J. Bahlis, MD, Douglas A. Stewart, MD, Mary Lynn Savoie, MD, Christopher Brown, MD, Andrew Daly, MD, Ahsan Chaudhry, MD, Jan Storek, MD, PhD, James A. Russell, MBBChir, FRCPE
Journal: Blood
Blood (2006) 108 (11): 3029.
https://doi.org/10.1182/blood.V108.11.3029.3029
Published: 2006
Journal Articles

Dose Intensive Induction Chemotherapy Does Not Decrease Tumor Contamination of Autograft or Improve Survival for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant.

Farzana A. Sayani, MD, Nizar J. Bahlis, MD, Peter Faris, PhD, Mary Lynn Savoie, MD, Ahsan Chaudhry, MD, Oluyemi Jeje, MD, Christopher B. Brown, MD, James A. Russell, MBBChir, FRCPE, Douglas A. Stewart, MD
Journal: Blood
Blood (2005) 106 (11): 2932.
https://doi.org/10.1182/blood.V106.11.2932.2932
Published: 2005
Journal Articles

The Influence of Adding Low-Dose (400cGy) Total Body Irradiation (TBI) on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukaemia (AML) with Myeloablative Conditioning Incorporating Daily Intravenous Busulfan, Fludarabine and Low-Dose Antithymocyte Globulin.

Mary Lynn Savoie, MD, Alexander Balogh, MD, M. Ahsan Chaudhry, MD, Oluyemi Jeje, MD, Douglas A. Stewart, MD, Nizar J. Bahlis, MD, Jan Storek, MD, PhD, Christopher B. Brown, MD, PhD, Diana M. Quinlan, A. Robert Turner, MD, Loree M. Larratt, MD, James A. Russell, MBBChir, FRCPE
Journal: Blood
Blood (2005) 106 (11): 2733.
https://doi.org/10.1182/blood.V106.11.2733.2733
Published: 2005
Journal Articles

Once Daily IV Busulfan Given with Fludarabine in Allogeneic Stem Cell Transplantation Conditioning: High vs Low Busulfan AUC Does Not Alter Toxicities or Transplant Outcome.

Michelle Geddes, MD, Shabal B. Kangarloo, MSc, Farrukh Naveed, BSc, Ahsan M. Chaudhry, MD, Oluyemi Jeje, MD, Mary L. Savoie, MD, Nizar J. Bahlis, MD, Douglas A. Stewart, MD, Christopher Brown, MD, Jan Storek, MD, PhD, Diana Quinlan, RN, Borje Andersson, MD, James A. Russell, MBBChir
Journal: Blood
Blood (2005) 106 (11): 1763.
https://doi.org/10.1182/blood.V106.11.1763.1763
Published: 2005